Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer

Affiliations

• ¹ Laboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICET, Vuelta de Obligado 2490, C1428ADN, Buenos Aires, Argentina.
• ² New York Genome Center, New York, NY, USA.
• ³ Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
• ⁴ Universidad de Buenos Aires (UBA), Facultad de Ciencias Exactas y Naturales, Departamento de Fisiología, Biología Molecular y Celular and CONICET-UBA, Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE), C1428EHA, Buenos Aires, Argentina.
• ⁵ Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.
• ⁶ Servicio de Ginecología, Sanatorio Sagrado Corazón, Buenos Aires, Argentina.
• ⁷ Laboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICET, Vuelta de Obligado 2490, C1428ADN, Buenos Aires, Argentina. patriciaelizalde@ibyme.conicet.gov.ar.
• ⁸ Laboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICET, Vuelta de Obligado 2490, C1428ADN, Buenos Aires, Argentina. rcordorusso@gmail.com.